Abbott's Architect: Technological Coup or Marketing Feat?
Executive Summary
Customers want more integrated testing and less cumbersome, cheaper connectivity in diagnostic testing. So Abbott this year launched its next generation of analyzers, which incorporates immunoassay, hematology, and chemistry into one system. But some critics claim the new analyzers fall far short of the integration goal and are more of a marketing coup than a technology breakthrough.